In silico identification of an interferon inhibitor

M. Kaiser, C. Ottmann

Research output: Contribution to journalArticleAcademicpeer-review


Inhibition of IFNa–IFNR: Interferon (IFN) is an important signaling molecule and antiviral therapeutic agent. However, in certain diseases like type I diabetes, IFN action can be harmful. Schneider and co-workers recently reported the identification of the first IFNa–IFNR inhibitor via in silico screening, which binds to IFNa and impedes interferon signaling in cells.
Original languageEnglish
Pages (from-to)555-557
Number of pages3
Issue number4
Publication statusPublished - 2012


Dive into the research topics of 'In silico identification of an interferon inhibitor'. Together they form a unique fingerprint.

Cite this